AI assistant
HAEMONETICS CORP — Director's Dealing 2010
Oct 29, 2010
31565_dirs_2010-10-29_b6cf6de4-7083-4c2c-a86b-8b8364355ecd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-10-28
Reporting Person: LOPEZ ALICIA R (VP, Corporate Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-10-28 | Common Stock | D | 71.0000 | $55.1900 | Disposed | 10938.0000 | Direct |
| 2010-10-28 | Common Stock | D | 71.0000 | $55.1900 | Disposed | 10867.0000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 100.0000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $26.1050 | 2014-05-05 | Common Stock (10000) | 10000.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $31.6600 | 2012-04-29 | Common Stock (20000) | 20000.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $33.1500 | 2011-04-30 | Common Stock (17000) | 17000.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $41.1500 | 2012-07-27 | Common Stock (17000) | 17000.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $51.0700 | 2014-10-24 | Common Stock (14159) | 14159.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $52.7600 | 2013-05-05 | Common Stock (14891) | 14891.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $52.9400 | 2016-10-27 | Common Stock (7732) | 7732.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $54.5500 | 2015-10-22 | Common Stock (14294) | 14294.0000 | Direct |
Footnotes
F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.
F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
F4: Grant to reporting person of right to buy shares of common stock exercisable 100% on 4/1/2011. Grant was made under 2005 Long Term Incentive Compensation Plan.